Friday 9 December 2016

BIOTECHNO 2017 --- cfp

[Apologies if you got multiple copies of this email. This message is
sent to . If you'd like to opt out of these
announcements, information on how to unsubscribe is available at the
bottom of this email.]

[apologies for cross-posting!]


Call for Contributions
Inform the Chair: with the Title of your Contribution
Submission URL: 
https://www.iariasubmit.org/conferences/submit/newcontribution.php?event=BIOTECHNO+2017+Special 
Please select Track Preference as MLPM


———————————————————
Special track

MLPM: Machine Learning Approaches to Precision Medicine
Chair and Coordinator:
Alexandru Floares, Md, PhD, President of SAIA Institute - Cluj, Romania
alexandru.floares@saia-institute.org

Co-Chair:
Dr. Andrea Bracciali, SICSA Lecturer, University of Stirling, UK
abb@cs.stir.ac.uk

along with
BIOTECHNO 2017, May 21 - 25, 2017 - Barcelona, Spain
The Ninth International Conference on Bioinformatics, Biocomputational Systems and Biotechnologies
———————————————————

The common biomedical community conception is that Precision Medicine’s goals can be reached only by increasing the accuracy of wet lab measurements. The results of biological experiments enter more and more into the realm of Big Data. Big Data do not talk themselves. Data should be preprocessed and analyzed. Moreover, identifying differentially expressed genes should not be the final result of the bioinformatic analysis, being an incomplete response to a potentially significant biomedical question. This is why we will not often see studies reporting the results of a t-test or similar algorithms, for a classification problem, in other fields than biomedical research. Most of them end with a classifier, developed using machine learning techniques.
So, accurate measurements of informative classes of biomedical variables, either molecules or extracted from medical images, combined with adequate machine learning methods, could lead to Precision Medicine. These can be used to develop highly accurate, robust (generalizing well to new cases) and transparent (easy to understand) predictive models. However, biological systems are highly redundant, and this is related to their amazing robustness. The usual machine learning approach, exclusively focused on identifying the minimal subset of relevant variables, while perfectly justified, preclude redundancy understanding and exploiting. Thus, new machine learning methods or adapting the existing ones is needed.
The special session opens to everybody as well as industrial partners to make contributions in this area.
Topics for this session include but are not limited to:
  •   Predictive models for diagnosis, prognosis and response to treatment
  •   Biomedical image processing and analysis
  •   Analysis of high-throughput biotechnology data
  •   Machine learning integration with Electronic Health Records
  •   Machine learning approaches to liquid biopsy
  •   Machine learning approaches to redundancy understanding and exploiting


        ********************************************************************************













        (https://lists.mcs.anl.gov/mailman/listinfo/hpc-announce
          If you do not remember your password (which is needed to change these options), you can reset it using the "Unsubscribe or Edit Options" button at the bottom of the page.



        (https://lists.mcs.anl.gov/mailman/listinfo/hpc-announce)






        .
        ********************************************************************************


        No comments:

        Post a Comment